Efficacy and safety of a new immunostimulating bacterial lysate in the prophylaxis of acute lower respiratory tract infections. A randomised, open, controlled clinical trial.
Rossi
Sandro
S
Pneumology Operative Unit, Azienda Sanitaria Locale N(o) 4, Terni, Italy.
Tazza
Roberto
R
D000276:Adjuvants, Immunologic / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001419:Bacteria / Q000276:immunology*; D001428:Bacterial Vaccines / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D003371:Cough / Q000209:etiology / Q000473:pathology; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010146:Pain / Q000209:etiology; D012141:Respiratory Tract Infections / Q000150:complications / Q000517:prevention & control*; D013183:Sputum
D000276:Adjuvants, Immunologic; D000900:Anti-Bacterial Agents; D001428:Bacterial Vaccines